Fouad Y et al
If the executive order can pave the way for doing objective, scientific research with this compound, it would help us understand whether it is truly a better psychedelic therapy than others. No psychedelic has been approved in the United States, but a number of them are being studied in large trials for various mental health conditions, including psilocybin, MDMA and LSD
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach
After adjusting for other factors, they found that the semaglutide users were overall 50% more likely to experience hair loss compared to the other group
Gastrointestinal issues Side effects can include diarrhea (if fat intake is high), bloating, constipation, heartburn, and stomach problems
No clinical trial has ever tested this combination